Drug Central Nervous System

Motpoly Xr

Payments companies reported to CMS as associated with Motpoly Xr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$149Kassociated payments (2023-2025)
1,861clinicians with associated payments
1company reporting

By year

2023 $1,500
2024 $25K
2025 $122K

Payments reported as associated with Motpoly Xr, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $53K
Neurology With Special Qualifications In Child Neurology $34K
Epilepsy $20K
Family $10K
Physician Assistant $4,244
Clinical Neurophysiology $3,993

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Motpoly Xr

These are the largest totals companies reported as associated with Motpoly Xr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Katherine Labiner Austin, TX Epilepsy $15,728.80
James Wheless Memphis, TN Neurology With Special Qualifications In Child Neurology $15,500.00
Deepti Zutshi Detroit, MI Neurology (Psychiatry & Neurology) $6,019.13
Jun Park Cleveland, OH Neurology With Special Qualifications In Child Neurology $4,398.22
Selim Benbadis Tampa, FL Neurology (Psychiatry & Neurology) $2,598.17
Shifteh Sattar San Diego, CA Neurology With Special Qualifications In Child Neurology $2,559.13
Ammar Kheder Grand Rapids, MI Epilepsy $2,500.00
Matthew Luedke Durham, NC Clinical Neurophysiology $2,500.00
Takijah Heard Evanston, IL Neurology With Special Qualifications In Child Neurology $2,500.00
Rebecca Odwyer Chicago, IL Neurology (Psychiatry & Neurology) $1,750.00

Prescribed Motpoly Xr?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.